RE: Contracts, collaboration and refinancing - new note out9 Nov 2023 15:22
This is a fascinating article. The potential market value of CZT products is huge. I have always wondered why Kromek is not an M&A target for bigger players? Especially as the share price is so depressed against a proposed fair value. I appreciate there are three business models are play for Kromek, but the upside in this vertical is huge and the IP surely carries great value to bigger organisations. They could target Kromek for this IP, and then just spin out the other two business models if it so wanted. Anyone else thought about Kromek maybe being a target and why no one has moved on it?